Cheni Kwok

55 year

Health Technology

Consumer Services

Profile

Cheni Kwok worked as an Associate Director of Business Development at Exelixis, Inc. and as a Director of Business Development at Celera Group.
She was also the Senior Vice President of Business Development at Poniard Pharmaceuticals, Inc. In addition, she worked as a Manager at GlaxoSmithKline Pharmaceuticals Ltd.
Dr. Kwok received an undergraduate degree from Imperial College London and a doctorate degree from the University of Cambridge.

Former positions of Cheni Kwok

Companies	Position	End
Celera Group Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD	Corporate Officer/Principal	02/01/2006
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	Corporate Officer/Principal	02/01/2004
EXELIXIS, INC.	Corporate Officer/Principal	-
PONIARD PHARMACEUTICALS, INC.	Corporate Officer/Principal	-

See the detail of Cheni Kwok's experience

Training of Cheni Kwok

Imperial College London	Undergraduate Degree
University of Cambridge	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Cheni Kwok's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
PONIARD PHARMACEUTICALS, INC.	Health Technology
EXELIXIS, INC.	Health Technology
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	Health Technology

Private companies	1
Celera Group Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD	Health Technology